Key Takeaways
- • Bain Capital has agreed to acquire British vitamins and supplements company Vitabiotics in a transaction valued at approximately £900 million, with Bain's Asian private equity team leading the investment.
- • The acquisition encompasses the wider Vitabiotics Group, including India-based Meyer Organics and African operations such as VB Egypt, expanding Bain's exposure to the global health and wellness sector.
- • Vitabiotics operates a portfolio of market-leading supplement brands including Wellman, Wellwoman, Pregnacare, and Wellbaby, distributed through pharmacies and retailers primarily in the UK market.
- • Chief executive Tej Lalvani, son of founder Kartar Lalvani (who established the company in 1971), attributed the transaction to structural shifts in consumer demand for health and wellness products accelerated by the Covid-19 pandemic.
- • Rothschild & Co advised Bain Capital on the transaction, while Houlihan Lokey represented Vitabiotics, with the deal reflecting continued international investor appetite for UK-based companies with established global operations.
Summary
Bain Capital has secured an agreement to acquire Vitabiotics, a London-based vitamins and supplements manufacturer, in a transaction valuing the business at approximately £900 million. The deal represents a significant entry point for Bain's Asian private equity division into the consumer health sector, with the acquisition encompassing not only the UK-based parent company but also its affiliated operations across Asia and Africa, including Meyer Organics in India and VB Egypt.
Vitabiotics has established itself as a substantial player in the nutritional supplements market, with a diversified portfolio of brands targeting specific consumer demographics. The company's flagship products—Wellman and Wellwoman for gender-specific nutritional support, Pregnacare for maternal health, and Wellbaby for infant nutrition—command significant shelf space in UK pharmacies and retail channels. The company's segmented approach to product development has enabled it to build market-leading positions in pregnancy and children's nutrition categories.
Chief executive Tej Lalvani, who is also known for his appearance as an investor on the BBC's Dragons' Den programme, framed the acquisition as a recognition of fundamental shifts in consumer behavior. Lalvani noted that post-pandemic consumer attitudes have increasingly prioritized quality of life, preventive nutrition, and wellness-focused lifestyle choices. This structural demand evolution has likely enhanced Vitabiotics' strategic value to a global alternative asset manager seeking exposure to secular growth trends in health and wellness.
Lalvani, whose father Kartar Lalvani founded the company in 1971, emphasized the importance of attracting international capital to UK-based businesses and retaining wealth creation within the country. Though now based in the United Arab Emirates, Lalvani maintains active involvement with the UK operations. Financial advisory roles were split between the parties: Rothschild & Co advised Bain Capital, while Houlihan Lokey represented Vitabiotics. The transaction reflects broader momentum in cross-border M&A targeting UK companies with established international operational footprints.
Vitabiotics has established itself as a substantial player in the nutritional supplements market, with a diversified portfolio of brands targeting specific consumer demographics. The company's flagship products—Wellman and Wellwoman for gender-specific nutritional support, Pregnacare for maternal health, and Wellbaby for infant nutrition—command significant shelf space in UK pharmacies and retail channels. The company's segmented approach to product development has enabled it to build market-leading positions in pregnancy and children's nutrition categories.
Chief executive Tej Lalvani, who is also known for his appearance as an investor on the BBC's Dragons' Den programme, framed the acquisition as a recognition of fundamental shifts in consumer behavior. Lalvani noted that post-pandemic consumer attitudes have increasingly prioritized quality of life, preventive nutrition, and wellness-focused lifestyle choices. This structural demand evolution has likely enhanced Vitabiotics' strategic value to a global alternative asset manager seeking exposure to secular growth trends in health and wellness.
Lalvani, whose father Kartar Lalvani founded the company in 1971, emphasized the importance of attracting international capital to UK-based businesses and retaining wealth creation within the country. Though now based in the United Arab Emirates, Lalvani maintains active involvement with the UK operations. Financial advisory roles were split between the parties: Rothschild & Co advised Bain Capital, while Houlihan Lokey represented Vitabiotics. The transaction reflects broader momentum in cross-border M&A targeting UK companies with established international operational footprints.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.
